Table 4 Late radiotherapy toxicities (EORTC/RTOG criteria)

From: Phase I trial of docetaxel, cisplatin and concurrent radical radiotherapy in locally advanced oesophageal cancer

  

Dose level

 

Toxicity

Worst grade

1 ( n =6)

2 ( n =6)

3 ( n =3)

4 ( n =3)

5 ( n =3)

6 ( n =3)

Total (%)

Esophageal

1

4

2

1

0

1

1

9 (37.5)

Skin

2

2

0

0

0

1

0

3 (12.5)

Pulmonary

1

2

2

0

0

0

0

4 (16.7)